Eli Lilly and Seamless Therapeutics Forge Billion-Dollar Alliance to Pioneer Gene-Edited Therapies for Hearing Loss
DRESDEN, GERMANY and LEXINGTON, MASS – In a landmark announcement on January 29, 2026, the global pharmaceutical giant Eli Lilly and Company formalized a comprehensive worldwide research collaboration and licensing…
